Biomarker testing in cancer management- can one size fit all?

Lynette M. Sholl, Balazs Halmos

Research output: Contribution to journalEditorialpeer-review

2 Scopus citations


Biomarker-guided treatment selection has transformed cancer management. Pruis et al. provide a powerful example of the challenges and promises of whole genome sequencing to match patients with advanced cancer for precision oncology studies and targeted therapies. Expanding genomic testing platforms are reviewed with a view towards future applications to inform clinical cancer research and practice.

Original languageEnglish (US)
Pages (from-to)1177-1179
Number of pages3
JournalBritish Journal of Cancer
Issue number7
StatePublished - Oct 19 2022

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Biomarker testing in cancer management- can one size fit all?'. Together they form a unique fingerprint.

Cite this